Literature DB >> 12972195

Identification of scFv antibody fragments that specifically recognise the heroin metabolite 6-monoacetylmorphine but not morphine.

Amir Moghaddam1, Tine Borgen, John Stacy, Louise Kausmally, Bjørg Simonsen, Ole J Marvik, Ole Henrik Brekke, Michael Braunagel.   

Abstract

Use of phage display of recombinant antibodies and large repertoire naïve antibody libraries for identifying antibodies of high specificity has been extensively reported. Nevertheless, there have been few reported antibodies to haptens that have originated from naïve antibody libraries with potential use in diagnostics. We have used chain shuffling of lead single-chain fragment variable (scFv) antibodies, isolated from a naïve antibody library, to screen for antibodies that specifically recognise the major metabolite of heroin, 6-monoacetylmorphine (6MAM). The antibodies were identified by screening high-density colonies of Escherichia coli expressing soluble scFv antibody fragments without prior expression on bacteriophage (phage display). The antibodies recognise 6MAM with affinities of 1-3x10(-7) M with no crossreactivity to morphine. These antibodies can potentially be used for developing a rapid immunoassay in drug-testing programs. To our knowledge, this is the first report of an antibody that distinguishes 6MAM from its de-acetylated form, morphine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12972195     DOI: 10.1016/s0022-1759(03)00109-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  16 in total

1.  Monoclonal Antibodies for Combating Synthetic Opioid Intoxication.

Authors:  Lauren C Smith; Paul T Bremer; Candy S Hwang; Bin Zhou; Beverly Ellis; Mark S Hixon; Kim D Janda
Journal:  J Am Chem Soc       Date:  2019-06-25       Impact factor: 15.419

Review 2.  Designing Human Antibodies by Phage Display.

Authors:  André Frenzel; Jonas Kügler; Saskia Helmsing; Doris Meier; Thomas Schirrmann; Michael Hust; Stefan Dübel
Journal:  Transfus Med Hemother       Date:  2017-08-25       Impact factor: 3.747

3.  Systematic Structure-Based Virtual Screening Approach to Antibody Selection and Design of a Humanized Antibody against Multiple Addictive Opioids without Affecting Treatment Agents Naloxone and Naltrexone.

Authors:  Chun-Hui Zhang; Kyungbo Kim; Zhenyu Jin; Fang Zheng; Chang-Guo Zhan
Journal:  ACS Chem Neurosci       Date:  2020-12-23       Impact factor: 4.418

4.  Beyond natural antibodies: the power of in vitro display technologies.

Authors:  Andrew R M Bradbury; Sachdev Sidhu; Stefan Dübel; John McCafferty
Journal:  Nat Biotechnol       Date:  2011-03       Impact factor: 54.908

Review 5.  Small molecule immunosensing using surface plasmon resonance.

Authors:  John Mitchell
Journal:  Sensors (Basel)       Date:  2010-08-04       Impact factor: 3.576

Review 6.  Phage display-derived human antibodies in clinical development and therapy.

Authors:  André Frenzel; Thomas Schirrmann; Michael Hust
Journal:  MAbs       Date:  2016-07-14       Impact factor: 5.857

7.  Recent advances in immunosensor for narcotic drug detection.

Authors:  Sonu Gandhi; Pankaj Suman; Ashok Kumar; Prince Sharma; Neena Capalash; C Raman Suri
Journal:  Bioimpacts       Date:  2015-12-28

8.  Generation of recombinant antibodies to rat GABAA receptor subunits by affinity selection on synthetic peptides.

Authors:  Sujatha P Koduvayur; Hélène A Gussin; Rajni Parthasarathy; Zengping Hao; Brian K Kay; David R Pepperberg
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

9.  Fully human antagonistic antibodies against CCR4 potently inhibit cell signaling and chemotaxis.

Authors:  Urs B Hagemann; Lavinia Gunnarsson; Solène Géraudie; Ulrike Scheffler; Remko A Griep; Herald Reiersen; Alexander R Duncan; Sergej M Kiprijanov
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

10.  Combining Yeast Display and Competitive FACS to Select Rare Hapten-Specific Clones from Recombinant Antibody Libraries.

Authors:  Yue Sun; Bhupal Ban; Andrew Bradbury; G A Shakeel Ansari; Diane A Blake
Journal:  Anal Chem       Date:  2016-09-08       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.